Amberstone Biosciences, an emerging biotherapeutics company with unique expertise in conditionally active immunotherapeutics, announced the completion…
Ascletis Pharma Inc. (1672.HK) and Suzhou Alphamab Co., Ltd. jointly announce today that Ascletis' subsidiary and Suzhou Alphamab have entered into an…